Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
Clinical trial NCT05484206 · RECRUITING
Trial details
- NCT number
- NCT05484206
- Sponsor
- Vir Biotechnology, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-21
- Primary completion
- 2026-09-25
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.